The global protein sequencing market size was estimated at USD 1.48 billion in 2025 and is projected to hit around USD 2.16 billion by 2035, growing at a CAGR of 3.8% during the forecast period from 2026 to 2035.
The global protein sequencing market has emerged as a critical segment within the broader proteomics and life sciences landscape. Protein sequencing refers to the process of determining the amino acid sequence of proteins, which is essential for understanding protein structure, function, and interactions. This information is crucial for drug discovery, disease diagnostics, and the development of targeted therapies.
With the rapid advancement of genomics, there has been a parallel rise in the importance of proteomics, as proteins are the functional molecules that execute genetic instructions. While genomics provides insights into potential biological functions, protein sequencing reveals actual biological activity, making it indispensable for modern biomedical research. The growing complexity of diseases such as cancer, neurodegenerative disorders, and autoimmune conditions has further emphasized the need for detailed protein analysis.
Technological advancements have significantly improved the efficiency and accuracy of protein sequencing. Mass spectrometry, in particular, has revolutionized the field by enabling high-throughput analysis and precise identification of proteins and their modifications. Edman degradation, although an older technique, still holds relevance in specific applications requiring precise N-terminal sequencing.
The market is also being driven by the increasing adoption of biologics and biosimilars. Pharmaceutical companies are investing heavily in protein characterization to ensure the safety, efficacy, and quality of their products. For example, monoclonal antibodies used in cancer immunotherapy require detailed sequencing to confirm their structure and function.
Additionally, the rise of contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) has expanded access to protein sequencing services. These organizations provide specialized expertise and infrastructure, enabling smaller companies and research institutions to leverage advanced sequencing technologies without significant capital investment.
Artificial Intelligence (AI) is playing a transformative role in the protein sequencing market by enhancing data analysis, improving accuracy, and accelerating research timelines. Protein sequencing generates vast amounts of complex data, particularly when using high-throughput techniques like mass spectrometry. AI and machine learning algorithms are increasingly being used to process and interpret this data efficiently.
One of the key applications of AI is in peptide identification and protein inference. Machine learning models can analyze mass spectrometry data to identify peptide sequences with high accuracy, even in complex samples. This reduces the time required for data analysis and minimizes errors associated with manual interpretation. For instance, AI algorithms can distinguish between similar peptide fragments, improving the reliability of sequencing results.
AI is also enabling the prediction of protein structures and functions based on sequence data. Tools such as deep learning models have demonstrated remarkable accuracy in predicting protein folding, which is essential for understanding biological mechanisms and drug interactions. This capability is particularly valuable in drug discovery, where understanding protein structure can significantly accelerate the development of new therapies.
Another important application of AI is in quality control and anomaly detection. AI systems can identify inconsistencies or errors in sequencing data, ensuring that only high-quality results are used for downstream applications. This is especially critical in biopharmaceutical manufacturing, where regulatory compliance and product quality are paramount.
Furthermore, AI is facilitating the integration of multi-omics data, combining proteomics with genomics and transcriptomics to provide a comprehensive understanding of biological systems. This holistic approach is driving innovation in personalized medicine and precision therapeutics.
| Report Coverage | Details |
| Market Size in 2026 | USD 1.54 Billion |
| Market Size by 2035 | USD 2.16 Billion |
| Growth Rate From 2026 to 2035 | CAGR of 3.8% |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | By Products & Services, By Technology, By Application, By End User, By Region |
| Market Analysis (Terms Used) | Value (USD Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled | Bioinformatics Solutions, Charles River Laboratories, Agilent Technologies, Inc., Proteome Factory, Rapid Novor Inc., Selvita, SGS, Shimadzu Corporation, Thermo Fisher Scientific Inc |
How did the regenerative and consumables segment dominate the Global Protein Sequencing market?
The regenerative and consumables segment is driven by the high recurring demand for buffers and enzymes required for continuous proteomics workflows. The expanding biopharmaceutical sector, where high-accuracy protein analysis is essential for monoclonal antibody development. The rise of high-throughput mass spectrometry and third-generation sequencing has created a critical need for specialized sample preparation kits, ensuring consistent revenue across academic and commercial sectors.
How did the protein sequencing services segment expect to hold the fastest-growing Global Protein Sequencing market in the coming years?
The protein sequencing services segment is driven by the high infrastructure costs and technical complexity of maintaining advanced mass spectrometry systems in-house. The integration of value-added bioinformatics and the rising demand for complex biologics characterization have positioned service providers as essential partners in the modern drug development pipeline.
How did the mass spectrometry segment account for the largest share in the Global Protein Sequencing market?
The mass spectrometry segment is driven by providing unmatched resolution and accuracy for protein quantification, significantly outperforming traditional sequencing methods. The integration of advanced liquid chromatography (LC-MS) and tandem techniques has drastically reduced processing times while increasing data precision for complex samples. As biopharmaceutical investment surges, mass spectrometry has become the indispensable standard for the rapid characterization of protein-based drugs and therapeutic biologics.
Mass spectrometry also supports high-throughput analysis, making it suitable for large-scale studies. The continuous development of advanced instruments and techniques is further enhancing its capabilities and driving its adoption.
Edman degradation is expected to grow steadily, particularly in applications requiring precise N-terminal sequencing. Although it is less commonly used than mass spectrometry, it remains a valuable tool for specific use cases where high accuracy is required.
How did the biotherapeutics segment account for the largest share in the Global Protein Sequencing market?
The biotherapeutics segment is driven by the stringent regulatory requirements that demand exhaustive validation of amino acid sequences to ensure patient safety and drug efficacy. The shift toward precision medicine for oncology and autoimmune diseases relies on high-resolution sequencing to optimize manufacturing and verify the structural integrity of targeted therapies.
How did the genetic engineering segment expect to hold the fastest-growing Global Protein Sequencing market in the coming years?
The genetic engineering segment is driven by the surge in synthetic biology and the critical need to validate protein expansions following CRISPR-Cas9 modifications. As researchers develop engineered proteins for vaccines and personalized medicine, high-throughput mass spectrometry provides the essential verification of structural and functional efficiency.
How did the pharmaceutical and biotechnology companies segment account for the largest share in the Global Protein Sequencing market?
The pharmaceutical and biotechnology companies segment is driven by the massive investment in target validation and precision medicine, which require rapid, high-volume protein identification. While maintaining sophisticated in-house capabilities, these firms significantly fuel the market. The massive development of complex biologics and fusion proteins.
How did the academic institution & research centers segment expect to hold the fastest-growing Global Protein Sequencing market in the coming years?
The academic institution & research centers segment is driven by the substantial public-private funding for foundational proteomics and biomarker discovery. As early adopters of high-throughput mass spectrometry and next-generation sequencing, these centers drive technical innovation in molecular biology. By leveraging shared core facilities, they efficiently manage large-scale studies and complex collaborations, consistently boosting the demand for advanced reagents and specialized sequencing services.
North America dominated the protein sequencing market due to its strong research infrastructure, presence of leading market players, and high investment in biotechnology. The region is a major hub for proteomics research and biopharmaceutical development.
Government support and funding programs further enhance the growth of the market in this region.
Asia Pacific is the fastest-growing region, driven by increasing investments in research and development, expanding biotechnology sector, and supportive government policies. Countries such as China, India, and Japan are активно investing in life sciences research, creating significant opportunities for market players.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2035. For this study, Nova one advisor, Inc. has segmented the protein sequencing market.
By Products & Services
By Technology
By Application
By End User
By Region
Protein Sequencing Market
Download Sample
Request Customization
Request Customization
Download Sample